Point72 Asset Management
ESPR

Point72 Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Point72 Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-260,000
Closed -$577K – 2088
2024
Q2 		$577K Buy
260,000
+60,000
+30% +$141K ﹤0.01% 1405
2024
Q1 		$536K Buy
+200,000
New +$486K ﹤0.01% 1629
2023
Q1 		– Sell
-150,000
Closed -$935K – 2319
2022
Q4 		$935K Buy
150,000
+100,000
+200% +$715K ﹤0.01% 1061
2022
Q3 		$335K Buy
+50,000
New +$343K ﹤0.01% 1218

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return